Africa Contraceptives Market cover

Africa Contraceptives Market by Products (Drugs [Tropical Contraceptives, Oral Contraceptives, and Contraceptive Injectable] and Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others]), Gender (Female and Male), and Region - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1696
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Africa contraceptives market size is projected to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing incidences of sexually transmitted diseases, rising government initiatives, and growing rates of unwanted pregnancies. Rising awareness regarding modern contraception and usage of oral pills is estimated to drive the market.

Contraception is the method to prevent unwanted pregnancy with the use of devices and drugs. It is also known as fertility control and birth control. It is used in the contraception interfere in the normal process of sperm & ovum fertilization to prevent pregnancy. It prevents from pregnancy under the process of implantation, ovulation, and fertilization with the help of barriers, surgical techniques, drugs, and medical devices.

Africa Contraceptives Market summary

The devices are available in various shapes including triangle, coil, loop, and T-shaped that are of metal or plastic materials. There are various types of contraceptives available which acts as a different point under the process from implantation through ovulation to fertilization. This method has its own risk and side effects. The contraceptive devices are majorly used in the hospitals and homecare. Covid-19 has impacted the contraceptives market as during lockdown going to physicians unnecessarily without emergency was limited.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising development of female contraceptives drugs and devices is estimated to fuel the market growth in the coming years.
  • Growing awareness among population is major factors spurring the market expansion during the forecast period.
  • Side effects due to consumption of contraceptives acts as main challenge that can hinder the market growth.
  • Availability of alternative contraceptives methods is anticipated to impede the market expansion in the coming years.
  • R&D investment and technological advancement in contraceptives market is expected to offer significant opportunities for the market players.

Scope of the Report

The report on the Africa contraceptives market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Africa Contraceptives Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Drugs [Tropical Contraceptives, Oral Contraceptives, and Contraceptive Injectable] and Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others]), Gender (Female and Male)

Regional Scope

Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bayer AG; Pfizer Inc.; Allergan PLC; Merk & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; SMB Corporation; Mayer Laboratories, Inc.; Okamoto Industries, Inc.; and Apothecus Pharmaceutical Corporation

Market Segment Insights:

Oral contraceptives segment is projected to account for a large market share

Based on products, the Africa contraceptives market is divided into drugs and devices.  The drugs segment is further segregated into tropical contraceptives, oral contraceptives, and contraceptive injectable. The devices segment is further classified as diaphragms, sponges, IUD, condoms, cervical caps, vaginal rings, and others. The oral contraceptives segment is expected to constitute a key share of the market during the forecast period owing to the easiest method of contraceptive, increasing number of unwanted pregnancies, and increasing occurrence of sexually transmitted diseases. The oral contraceptives taken in 2-3 days of unsafe sexual intercourse, so it helps to restrict implantation within uterus. However, the condoms segment is anticipated to expand at a rapid pace during the forecast period due to long term effect and effectiveness. To fulfill the growing demand for the products and also to monitor the women’s health is expected to boost the market.

Africa Contraceptives Market product

Male segment is projected to hold a key market share

On the basis of gender, the market is segmented into female and male. The male segment is expected to represent a key share of the market in the coming years due to rising number of commercialization of male birth control devices. On the other hand, the female segment is anticipated to expand at a rapid pace during the forecast period owing to rising rates of unwanted pregnancies. The government is taking initiatives to decrease the rate of unwanted pregnancies is expected to boost the market.

Segments

Segments Covered in the Report
The Africa contraceptives market has been segmented on the basis of

Products

  • Drugs
    • Tropical Contraceptives
    • Oral Contraceptives
    • Contraceptive Injectable
  • Devices
    • Diaphragms
    • Sponges
    • IUD
    • Condoms
    • Cervical Caps
    • Vaginal Rings
    • Others

Gender

  • Female
  • Male

Region

  • Africa

Key Players

  • Bayer AG
  • Pfizer Inc.
  • Allergan PLC
  • Merk & Co. Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • SMB Corporation
  • Mayer Laboratories, Inc.
  • Okamoto Industries, Inc.
  • Apothecus Pharmaceutical Corporation

Competitive Landscape

Key players competing in the Africa contraceptives market include Bayer AG; Pfizer Inc.; Allergan PLC; Merk & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; SMB Corporation; Mayer Laboratories, Inc.; Okamoto Industries, Inc.; and Apothecus Pharmaceutical Corporation. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.

Africa Contraceptives Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contraceptives Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Contraceptives Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Contraceptives Market - Supply Chain
  4.5. Global Contraceptives Market Forecast
     4.5.1. Contraceptives Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Contraceptives Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Contraceptives Market Absolute $ Opportunity
5. Global Contraceptives Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Contraceptives Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Contraceptives Demand Share Forecast, 2019-2026
6. North America Contraceptives Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Contraceptives Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Contraceptives Demand Share Forecast, 2019-2026
7. Latin America Contraceptives Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Contraceptives Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Contraceptives Demand Share Forecast, 2019-2026
8. Europe Contraceptives Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Contraceptives Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Contraceptives Demand Share Forecast, 2019-2026
9. Asia Pacific Contraceptives Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Contraceptives Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Contraceptives Demand Share Forecast, 2019-2026
10. Middle East & Africa Contraceptives Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Contraceptives Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Contraceptives Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Contraceptives Market: Market Share Analysis
  11.2. Contraceptives Distributors and Customers
  11.3. Contraceptives Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Bayer AG
     11.4.2. Pfizer Inc.
     11.4.3. Allergan PLC
     11.4.4. Merk & Co. Inc.
     11.4.5. Teva Pharmaceuticals Industries Ltd.
     11.4.6. SMB Corporation
     11.4.7. Mayer Laboratories, Inc.
     11.4.8. Ok

Segments Covered in the Report
The Africa contraceptives market has been segmented on the basis of

Products

  • Drugs
    • Tropical Contraceptives
    • Oral Contraceptives
    • Contraceptive Injectable
  • Devices
    • Diaphragms
    • Sponges
    • IUD
    • Condoms
    • Cervical Caps
    • Vaginal Rings
    • Others

Gender

  • Female
  • Male

Region

  • Africa

Key Players

  • Bayer AG
  • Pfizer Inc.
  • Allergan PLC
  • Merk & Co. Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • SMB Corporation
  • Mayer Laboratories, Inc.
  • Okamoto Industries, Inc.
  • Apothecus Pharmaceutical Corporation

Key players competing in the Africa contraceptives market include Bayer AG; Pfizer Inc.; Allergan PLC; Merk & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; SMB Corporation; Mayer Laboratories, Inc.; Okamoto Industries, Inc.; and Apothecus Pharmaceutical Corporation. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.

Africa Contraceptives Market keyplayers

Buy Report